CD200 as a prognostic factor in acute myeloid leukaemia
Open Access
- 25 January 2007
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 21 (3) , 566-568
- https://doi.org/10.1038/sj.leu.2404559
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- CD200 is a new prognostic factor in multiple myelomaBlood, 2006
- A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formationImmunology Letters, 2006
- Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulationProceedings of the National Academy of Sciences, 2006
- Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200The Journal of Immunology, 2003
- Anti-CD200R Ameliorates Collagen-Induced Arthritis in MiceClinical Immunology, 2002
- CD200 and membrane protein interactions in the control of myeloid cellsTrends in Immunology, 2002
- Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)Science, 2000
- Lymphoid/Neuronal Cell Surface OX2 Glycoprotein Recognizes a Novel Receptor on Macrophages Implicated in the Control of Their FunctionImmunity, 2000
- The Phosphotyrosine Interaction Domain of SHC Recognizes Tyrosine-phosphorylated NPXY MotifJournal of Biological Chemistry, 1995